Cargando…

Takes one to B1a: Dismantling the origin of mantle cell lymphoma

Therapeutic discovery for mantle cell lymphoma (MCL) has been hindered by a lack of preclinical mouse models that recapitulate human disease. In this issue, Pieters and colleagues (2021. J. Exp. Med. https://doi.org/10.1084/jem.20202280) establish a novel mouse model of MCL driven by overexpression...

Descripción completa

Detalles Bibliográficos
Autor principal: Beaudin, Anna E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Rockefeller University Press 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8449273/
https://www.ncbi.nlm.nih.gov/pubmed/34529750
http://dx.doi.org/10.1084/jem.20211482
_version_ 1784569397798502400
author Beaudin, Anna E.
author_facet Beaudin, Anna E.
author_sort Beaudin, Anna E.
collection PubMed
description Therapeutic discovery for mantle cell lymphoma (MCL) has been hindered by a lack of preclinical mouse models that recapitulate human disease. In this issue, Pieters and colleagues (2021. J. Exp. Med. https://doi.org/10.1084/jem.20202280) establish a novel mouse model of MCL driven by overexpression of cyclin D2 and identify fetal-derived B1a cells as putative cell of origin for MCL.
format Online
Article
Text
id pubmed-8449273
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Rockefeller University Press
record_format MEDLINE/PubMed
spelling pubmed-84492732022-04-04 Takes one to B1a: Dismantling the origin of mantle cell lymphoma Beaudin, Anna E. J Exp Med Insights Therapeutic discovery for mantle cell lymphoma (MCL) has been hindered by a lack of preclinical mouse models that recapitulate human disease. In this issue, Pieters and colleagues (2021. J. Exp. Med. https://doi.org/10.1084/jem.20202280) establish a novel mouse model of MCL driven by overexpression of cyclin D2 and identify fetal-derived B1a cells as putative cell of origin for MCL. Rockefeller University Press 2021-09-16 /pmc/articles/PMC8449273/ /pubmed/34529750 http://dx.doi.org/10.1084/jem.20211482 Text en © 2021 Beaudin http://www.rupress.org/terms/https://creativecommons.org/licenses/by-nc-sa/4.0/This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms/). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 International license, as described at https://creativecommons.org/licenses/by-nc-sa/4.0/).
spellingShingle Insights
Beaudin, Anna E.
Takes one to B1a: Dismantling the origin of mantle cell lymphoma
title Takes one to B1a: Dismantling the origin of mantle cell lymphoma
title_full Takes one to B1a: Dismantling the origin of mantle cell lymphoma
title_fullStr Takes one to B1a: Dismantling the origin of mantle cell lymphoma
title_full_unstemmed Takes one to B1a: Dismantling the origin of mantle cell lymphoma
title_short Takes one to B1a: Dismantling the origin of mantle cell lymphoma
title_sort takes one to b1a: dismantling the origin of mantle cell lymphoma
topic Insights
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8449273/
https://www.ncbi.nlm.nih.gov/pubmed/34529750
http://dx.doi.org/10.1084/jem.20211482
work_keys_str_mv AT beaudinannae takesonetob1adismantlingtheoriginofmantlecelllymphoma